Levosert® is a levonorgestrel intrauterine system (LNG-IUS) newly launched in the UK for contraception and management of heavy menstrual bleeding. It contains 52mg levonorgestrel (identical to Mirena®) in a reservoir mounted on a T-shaped polyethylene frame. Initially launch in April 2015 licensed for 3 years, Levosert has now been approved in the UK for 4 years use (February 2018).
Please read this guidance document in conjunction with any relevant clinical statements for this topic.
These can be found by visiting the Clinical Statements section.